Tectonic Therapeutics TECX Current ratio

Current ratio at other companies

ALN

Alnylam PharmaceuticalsALNY

3.1×+0.3×

Septerna, Inc.SEPN

5×-17.1×

Gyre Therapeutics, Inc.GYRE

4.3×-1.1×

RegenxbioRGNX

2.9×-0.3×

Opko HealthOPK

3.3×-0.1×

CelcuityCELC

12.3×+5.7×

FAQ

What is Tectonic Therapeutics's current ratio?

Tectonic Therapeutics (TECX) reported current ratio of 18.5× in Q1 2026.

How has Tectonic Therapeutics's current ratio changed year-over-year?

Tectonic Therapeutics's current ratio decreased by 19.2% year-over-year, from 22.9× to 18.5×.

What is the long-term trend for Tectonic Therapeutics's current ratio?

Over 5 years (2020 to 2025), Tectonic Therapeutics's current ratio has grown at a 10.6% compound annual growth rate (CAGR), from 16.1× to 26.6×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.